European Medicines Agency Validates Bristol Myers Squibb’s Application for Subcutaneous Nivolumab

View Full Size 

Download

• Full Size JPEG, 1497x206, 98.9 KB
• Small JPEG, 480x66, 36.6 KB
• Preview JPEG, 144x20, 17.1 KB
• Thumbnail JPEG, 120x17, 15.7 KB